The Antitumour Activity of a Curcumin and Piperine Loaded iRGD-Modified Liposome: In Vitro and In Vivo Evaluation
Molecules · 2023
DOI: 10.3390/molecules28186532 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, 2023. Verfasst von Yingzheng Wang und 7 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmacy, Fujian University of Traditional Chinese Medicine, Fuzhou 350122, China. Hauptthemen laut MEDLINE: Liposomes, Benzodioxoles, Curcumin, Piperidines. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fujian Province Science and Technology Association, the Ministry of Science and Technology of Fujian Province.
Abstract (Originalsprache)
Lung cancer is one of the most common cancers around the world, with a high mortality rate. Despite substantial advancements in diagnoses and therapies, the outlook and survival of patients with lung cancer remains dismal due to drug tolerance and malignant reactions. New interventional treatments urgently need to be explored if natural compounds are to be used to reduce toxicity and adverse effects to meet the needs of lung cancer clinical treatment. An internalizing arginine-glycine-aspartic acid (iRGD) modified by a tumour-piercing peptide liposome (iRGD-LP-CUR-PIP) was developed via co-delivery of curcumin (CUR) and piperine (PIP). Its antitumour efficacy was evaluated and validated via in vivo and in vitro experiments. iRGD-LP-CUR-PIP enhanced tumour targeting and cellular internalisation effectively. In vitro, iRGD-LP-CUR-PIP exhibited enhanced cellular uptake, suppression of tumour cell multiplication and invasion and energy-independent cellular uptake. In vivo, iRGD-LP-CUR-PIP showed high antitumour efficacy, mainly in terms of significant tumour volume reduction and increased weight and spleen index. Data showed that iRGD peptide has active tumour targeting and it significantly improves the penetration and cellular internalisation of tumours in the liposomal system. The use of CUR in combination with PIP can exert synergistic antitumour activity. This study provides a targeted therapeutic system based on natural components to improve antitumour efficacy in lung cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Pharmacy, Fujian University of Traditional Chinese Medicine, Fuzhou 350122, China.
Förderung
- Fujian Province Science and Technology Association
- the Ministry of Science and Technology of Fujian Province
Zitieren
APA
Wang, Y., Huang, X., Chen, H., Wu, Q., Zhao, Q., Fu, D., Liu, Q., & Wang, Y. (2023). The Antitumour Activity of a Curcumin and Piperine Loaded iRGD-Modified Liposome: In Vitro and In Vivo Evaluation. Molecules. https://doi.org/10.3390/molecules28186532
Vancouver
Wang Y, Huang X, Chen H, Wu Q, Zhao Q, Fu D, et al. The Antitumour Activity of a Curcumin and Piperine Loaded iRGD-Modified Liposome: In Vitro and In Vivo Evaluation. Molecules. 2023. doi:10.3390/molecules28186532
BibTeX
@article{Wang2023,
author = {Wang, Yingzheng and Huang, Xunhua and Chen, Hanzhi and Wu, Qianyuan and Zhao, Qianqian and Fu, Dezhuang and Liu, Qinghua and Wang, Yinghao},
title = {The Antitumour Activity of a Curcumin and Piperine Loaded iRGD-Modified Liposome: In Vitro and In Vivo Evaluation},
journal = {Molecules},
year = {2023},
doi = {10.3390/molecules28186532}
}
EUVIMED